Doximity, Inc. $DOCS Shares Acquired by Legal & General Group Plc

Legal & General Group Plc grew its holdings in Doximity, Inc. (NASDAQ:DOCS) by 41.0% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 268,864 shares of the company’s stock after acquiring an additional 78,247 shares during the period. Legal & General Group Plc’s holdings in Doximity were worth $16,492,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the business. Vanguard Group Inc. lifted its position in Doximity by 8.8% during the first quarter. Vanguard Group Inc. now owns 12,194,492 shares of the company’s stock valued at $707,646,000 after purchasing an additional 990,923 shares during the period. William Blair Investment Management LLC lifted its holdings in shares of Doximity by 13.8% in the 2nd quarter. William Blair Investment Management LLC now owns 5,219,394 shares of the company’s stock valued at $320,158,000 after buying an additional 634,927 shares during the period. Geode Capital Management LLC boosted its stake in shares of Doximity by 7.7% in the second quarter. Geode Capital Management LLC now owns 3,639,898 shares of the company’s stock worth $223,829,000 after buying an additional 261,319 shares during the last quarter. Invesco Ltd. grew its holdings in Doximity by 54.8% during the first quarter. Invesco Ltd. now owns 1,969,326 shares of the company’s stock worth $114,280,000 after acquiring an additional 696,923 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in Doximity by 130.4% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,966,801 shares of the company’s stock valued at $114,133,000 after acquiring an additional 1,113,076 shares in the last quarter. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Insider Buying and Selling at Doximity

In other Doximity news, Director Kira Scherer Wampler sold 2,000 shares of the stock in a transaction that occurred on Monday, November 3rd. The stock was sold at an average price of $66.44, for a total transaction of $132,880.00. Following the completion of the transaction, the director owned 19,839 shares of the company’s stock, valued at $1,318,103.16. This represents a 9.16% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Timothy S. Cabral sold 20,000 shares of Doximity stock in a transaction that occurred on Wednesday, September 24th. The stock was sold at an average price of $75.00, for a total value of $1,500,000.00. Following the completion of the sale, the director directly owned 3,221 shares in the company, valued at $241,575. This represents a 86.13% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 32,000 shares of company stock valued at $2,339,580 over the last quarter. 31.30% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

DOCS has been the topic of several recent research reports. KeyCorp upped their price objective on Doximity from $75.00 to $80.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 8th. Wells Fargo & Company raised their price target on shares of Doximity from $55.00 to $62.00 and gave the company an “equal weight” rating in a research report on Monday, August 4th. Canaccord Genuity Group decreased their price objective on shares of Doximity from $67.00 to $58.00 and set a “hold” rating for the company in a research report on Monday, November 10th. Piper Sandler increased their target price on shares of Doximity from $65.00 to $69.00 and gave the stock an “overweight” rating in a research note on Monday, August 11th. Finally, BMO Capital Markets began coverage on Doximity in a research note on Thursday, November 13th. They issued a “market perform” rating and a $55.00 price target for the company. Two analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating, eight have given a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Doximity has an average rating of “Moderate Buy” and an average target price of $68.22.

Doximity Stock Up 1.0%

DOCS opened at $51.50 on Friday. The firm’s fifty day simple moving average is $63.18 and its two-hundred day simple moving average is $61.82. Doximity, Inc. has a 52-week low of $46.04 and a 52-week high of $85.21. The company has a market cap of $9.70 billion, a price-to-earnings ratio of 51.50, a PEG ratio of 4.10 and a beta of 1.36.

Doximity (NASDAQ:DOCS) last released its earnings results on Thursday, November 6th. The company reported $0.45 EPS for the quarter, topping analysts’ consensus estimates of $0.38 by $0.07. Doximity had a net margin of 36.60% and a return on equity of 21.75%. During the same quarter in the previous year, the company earned $0.30 earnings per share. The firm’s quarterly revenue was up 23.2% compared to the same quarter last year. Doximity has set its FY 2026 guidance at EPS. Q3 2026 guidance at EPS. On average, research analysts forecast that Doximity, Inc. will post 0.99 EPS for the current year.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.